| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |